Smallpox Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 50 pages | ID: SE3BF34B9571EN
VPAResearch

Abstracts

Smallpox Drug pipeline report- 2020 is an annual R&D review of Smallpox pipeline candidates. The report presents the current status of all major Smallpox therapeutic compounds. Detailed insights into Smallpox pipeline development, current status, companies, drug profiles and Smallpox preclinical and clinical trials are included.

2020 Smallpox Pipeline Market Insights
Smallpox disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Smallpox therapies, pipeline by phase and others are included.

Smallpox pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Smallpox Therapeutic Drug candidates
Both active and inactive Smallpox pipeline drug candidates are included in the report

Smallpox Clinical Trials and preclinical Studies
Smallpox In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Smallpox pipeline market developments
Smallpox Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Smallpox pipeline companies in active development
The report analyzes Smallpox pipeline of the below companies-

BioFactura Inc, CEL-SCI Corp, Chimerix Inc, CJ HealthCare Corp, EpiVax Inc, Polyrizon Ltd, SIGA Technologies Inc, Tonix Pharmaceuticals Holding Corp, Viraze

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
9 Companies investing in Smallpox pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Smallpox pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. SMALLPOX PIPELINE MARKET INSIGHTS, 2020

1.1 Smallpox Disease Overview
1.2 Smallpox Drug Pipeline Snapshot, 2020
  1.2.1 Smallpox Pipeline Drugs by Phase
  1.2.2 Smallpox Pipeline Drugs by Company
  1.2.3 Smallpox Pipeline Drugs by Mechanism of Action
  1.2.4 Smallpox Pipeline Drugs by Route of Administration

2. SMALLPOX COMPANY WISE PIPELINE DETAILS

BioFactura Inc Smallpox Pipeline Drugs
  Company Profile
  Drug Candidate Details
CEL-SCI Corp Smallpox Pipeline Drugs
  Company Profile
  Drug Candidate Details
Chimerix Inc Smallpox Pipeline Drugs
  Company Profile
  Drug Candidate Details
CJ HealthCare Corp Smallpox Pipeline Drugs
  Company Profile
  Drug Candidate Details
EpiVax Inc Smallpox Pipeline Drugs
  Company Profile
  Drug Candidate Details
Polyrizon Ltd Smallpox Pipeline Drugs
  Company Profile
  Drug Candidate Details
SIGA Technologies Inc Smallpox Pipeline Drugs
  Company Profile
  Drug Candidate Details
Tonix Pharmaceuticals Holding Corp Smallpox Pipeline Drugs
  Company Profile
  Drug Candidate Details
Viraze Smallpox Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. SMALLPOX DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. SMALLPOX PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts